Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
16.08
-0.50 (-3.02%)
At close: Aug 21, 2026
-44.74% (1Y)
| Market Cap | 186.25M +22.2% |
| Revenue (ttm) | 92.94M +385.7% |
| Net Income | 3.27M +1,933.5% |
| EPS | 0.24 +691.8% |
| Shares Out | 11.58M |
| PE Ratio | 65.81 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 16,971 |
| Open | 16.90 |
| Previous Close | 16.58 |
| Day's Range | 14.10 - 17.19 |
| 52-Week Range | 14.10 - 36.96 |
| Beta | -1.73 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 7, 2026 |